TWELVE MONTHS OF EMICIZUMAB PROPHYLAXIS IN A SEVERE HAEMOPHILIA A MAN WITH INHIBITOR WHO FAILED IMMUNE TOLERANCE INDUCTIONS: EFFECTIVENESS, ECONOMIC OUTCOME, AND SAFETY R.M. Camelo; T.C. Medeiros; D.G.B. Albuquerque; N. Dantas-Silva; J. Álvares-Teodoro;

SIX MONTHS OF EMICIZUMAB PROPHYLAXIS IN A WOMAN WITH MILD HEMOPHILIA A AND INHIBITOR: EFFECTIVENESS, ECONOMIC OUTCOME, AND SAFETY R.M. Camelo; E.S. Casaretto; S.S. Figueiredo; N. Dantas-Silva; J. Álvares-Teodoro;

CARDIOVASCULAR RISK FACTOR PROFILE AMONG NORTH-EASTERN BRAZILIAN ADULTS WITH HAEMOPHILIA R.M. Camelo; B.P. Duarte; M.C.B. Moura; C.C. Deelder; N.C.M. Costa; I.M. Costa; C.G.P. Roncal; A.M. Vanderlei; T.M.R. Guimaraes; S. Gouw; S.M. Rezende; J.V.D. Bom;